A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers. Beginning Q2 2024, Cardio Diagnostics ...

Once integration is completed, the partners plan to accelerate commercial rollout across India, anticipated in 2026.

Advances in genetic testing are improving the understanding of a variety of inherited cardiovascular diseases, but not all cardiologists are aware of the benefits and risks of incorporating genetic ...

Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.

resTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease tests Both organizations are focused on expanding their influence within ...

Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...

A recent study found that negative autopsy/sudden unexplained death (SUD) constituted the most common observation in sudden young deaths, followed by coronary artery disease ...